Knee Bursitis Treatment Market
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Knee Bursitis Treatment Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Medication
1.2.3 Surgery Therapy
1.2.4 Others
1.3 Market by Application
1.3.1 Global Knee Bursitis Treatment Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Dermatology Centers
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Knee Bursitis Treatment Market Perspective (2017-2028)
2.2 Knee Bursitis Treatment Growth Trends by Region
2.2.1 Knee Bursitis Treatment Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Knee Bursitis Treatment Historic Market Size by Region (2017-2022)
2.2.3 Knee Bursitis Treatment Forecasted Market Size by Region (2023-2028)
2.3 Knee Bursitis Treatment Market Dynamics
2.3.1 Knee Bursitis Treatment Industry Trends
2.3.2 Knee Bursitis Treatment Market Drivers
2.3.3 Knee Bursitis Treatment Market Challenges
2.3.4 Knee Bursitis Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Knee Bursitis Treatment Players by Revenue
3.1.1 Global Top Knee Bursitis Treatment Players by Revenue (2017-2022)
3.1.2 Global Knee Bursitis Treatment Revenue Market Share by Players (2017-2022)
3.2 Global Knee Bursitis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Knee Bursitis Treatment Revenue
3.4 Global Knee Bursitis Treatment Market Concentration Ratio
3.4.1 Global Knee Bursitis Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Knee Bursitis Treatment Revenue in 2021
3.5 Knee Bursitis Treatment Key Players Head office and Area Served
3.6 Key Players Knee Bursitis Treatment Product Solution and Service
3.7 Date of Enter into Knee Bursitis Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Knee Bursitis Treatment Breakdown Data by Type
4.1 Global Knee Bursitis Treatment Historic Market Size by Type (2017-2022)
4.2 Global Knee Bursitis Treatment Forecasted Market Size by Type (2023-2028)
5 Knee Bursitis Treatment Breakdown Data by Application
5.1 Global Knee Bursitis Treatment Historic Market Size by Application (2017-2022)
5.2 Global Knee Bursitis Treatment Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Knee Bursitis Treatment Market Size (2017-2028)
6.2 North America Knee Bursitis Treatment Market Size by Country (2017-2022)
6.3 North America Knee Bursitis Treatment Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Knee Bursitis Treatment Market Size (2017-2028)
7.2 Europe Knee Bursitis Treatment Market Size by Country (2017-2022)
7.3 Europe Knee Bursitis Treatment Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Knee Bursitis Treatment Market Size (2017-2028)
8.2 Asia-Pacific Knee Bursitis Treatment Market Size by Country (2017-2022)
8.3 Asia-Pacific Knee Bursitis Treatment Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Knee Bursitis Treatment Market Size (2017-2028)
9.2 Latin America Knee Bursitis Treatment Market Size by Country (2017-2022)
9.3 Latin America Knee Bursitis Treatment Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Knee Bursitis Treatment Market Size (2017-2028)
10.2 Middle East & Africa Knee Bursitis Treatment Market Size by Country (2017-2022)
10.3 Middle East & Africa Knee Bursitis Treatment Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Novartis
11.1.1 Novartis Company Detail
11.1.2 Novartis Business Overview
11.1.3 Novartis Knee Bursitis Treatment Introduction
11.1.4 Novartis Revenue in Knee Bursitis Treatment Business (2017-2022)
11.1.5 Novartis Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Detail
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Knee Bursitis Treatment Introduction
11.2.4 Pfizer Revenue in Knee Bursitis Treatment Business (2017-2022)
11.2.5 Pfizer Recent Development
11.3 Merck
11.3.1 Merck Company Detail
11.3.2 Merck Business Overview
11.3.3 Merck Knee Bursitis Treatment Introduction
11.3.4 Merck Revenue in Knee Bursitis Treatment Business (2017-2022)
11.3.5 Merck Recent Development
11.4 Amgen
11.4.1 Amgen Company Detail
11.4.2 Amgen Business Overview
11.4.3 Amgen Knee Bursitis Treatment Introduction
11.4.4 Amgen Revenue in Knee Bursitis Treatment Business (2017-2022)
11.4.5 Amgen Recent Development
11.5 Bayer
11.5.1 Bayer Company Detail
11.5.2 Bayer Business Overview
11.5.3 Bayer Knee Bursitis Treatment Introduction
11.5.4 Bayer Revenue in Knee Bursitis Treatment Business (2017-2022)
11.5.5 Bayer Recent Development
11.6 AVEO Pharmaceuticals
11.6.1 AVEO Pharmaceuticals Company Detail
11.6.2 AVEO Pharmaceuticals Business Overview
11.6.3 AVEO Pharmaceuticals Knee Bursitis Treatment Introduction
11.6.4 AVEO Pharmaceuticals Revenue in Knee Bursitis Treatment Business (2017-2022)
11.6.5 AVEO Pharmaceuticals Recent Development
11.7 Bellicum Pharmaceuticals
11.7.1 Bellicum Pharmaceuticals Company Detail
11.7.2 Bellicum Pharmaceuticals Business Overview
11.7.3 Bellicum Pharmaceuticals Knee Bursitis Treatment Introduction
11.7.4 Bellicum Pharmaceuticals Revenue in Knee Bursitis Treatment Business (2017-2022)
11.7.5 Bellicum Pharmaceuticals Recent Development
11.8 MediaPharma
11.8.1 MediaPharma Company Detail
11.8.2 MediaPharma Business Overview
11.8.3 MediaPharma Knee Bursitis Treatment Introduction
11.8.4 MediaPharma Revenue in Knee Bursitis Treatment Business (2017-2022)
11.8.5 MediaPharma Recent Development
11.9 Merrimack Pharmaceuticals
11.9.1 Merrimack Pharmaceuticals Company Detail
11.9.2 Merrimack Pharmaceuticals Business Overview
11.9.3 Merrimack Pharmaceuticals Knee Bursitis Treatment Introduction
11.9.4 Merrimack Pharmaceuticals Revenue in Knee Bursitis Treatment Business (2017-2022)
11.9.5 Merrimack Pharmaceuticals Recent Development
11.10 Oncolys BioPharma
11.10.1 Oncolys BioPharma Company Detail
11.10.2 Oncolys BioPharma Business Overview
11.10.3 Oncolys BioPharma Knee Bursitis Treatment Introduction
11.10.4 Oncolys BioPharma Revenue in Knee Bursitis Treatment Business (2017-2022)
11.10.5 Oncolys BioPharma Recent Development
11.11 United Therapeutics
11.11.1 United Therapeutics Company Detail
11.11.2 United Therapeutics Business Overview
11.11.3 United Therapeutics Knee Bursitis Treatment Introduction
11.11.4 United Therapeutics Revenue in Knee Bursitis Treatment Business (2017-2022)
11.11.5 United Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Knee Bursitis Treatment Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Medication
Table 3. Key Players of Surgery Therapy
Table 4. Key Players of Others
Table 5. Global Knee Bursitis Treatment Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Knee Bursitis Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Knee Bursitis Treatment Market Size by Region (2017-2022) & (US$ Million)
Table 8. Global Knee Bursitis Treatment Market Share by Region (2017-2022)
Table 9. Global Knee Bursitis Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 10. Global Knee Bursitis Treatment Market Share by Region (2023-2028)
Table 11. Knee Bursitis Treatment Market Trends
Table 12. Knee Bursitis Treatment Market Drivers
Table 13. Knee Bursitis Treatment Market Challenges
Table 14. Knee Bursitis Treatment Market Restraints
Table 15. Global Knee Bursitis Treatment Revenue by Players (2017-2022) & (US$ Million)
Table 16. Global Knee Bursitis Treatment Market Share by Players (2017-2022)
Table 17. Global Top Knee Bursitis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Knee Bursitis Treatment as of 2021)
Table 18. Ranking of Global Top Knee Bursitis Treatment Companies by Revenue (US$ Million) in 2021
Table 19. Global 5 Largest Players Market Share by Knee Bursitis Treatment Revenue (CR5 and HHI) & (2017-2022)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Knee Bursitis Treatment Product Solution and Service
Table 22. Date of Enter into Knee Bursitis Treatment Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Knee Bursitis Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 25. Global Knee Bursitis Treatment Revenue Market Share by Type (2017-2022)
Table 26. Global Knee Bursitis Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 27. Global Knee Bursitis Treatment Revenue Market Share by Type (2023-2028)
Table 28. Global Knee Bursitis Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 29. Global Knee Bursitis Treatment Revenue Market Share by Application (2017-2022)
Table 30. Global Knee Bursitis Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 31. Global Knee Bursitis Treatment Revenue Market Share by Application (2023-2028)
Table 32. North America Knee Bursitis Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 33. North America Knee Bursitis Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 34. Europe Knee Bursitis Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 35. Europe Knee Bursitis Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 36. Asia-Pacific Knee Bursitis Treatment Market Size by Region (2017-2022) & (US$ Million)
Table 37. Asia-Pacific Knee Bursitis Treatment Market Size by Region (2023-2028) & (US$ Million)
Table 38. Latin America Knee Bursitis Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 39. Latin America Knee Bursitis Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 40. Middle East & Africa Knee Bursitis Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 41. Middle East & Africa Knee Bursitis Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 42. Novartis Company Detail
Table 43. Novartis Business Overview
Table 44. Novartis Knee Bursitis Treatment Product
Table 45. Novartis Revenue in Knee Bursitis Treatment Business (2017-2022) & (US$ Million)
Table 46. Novartis Recent Development
Table 47. Pfizer Company Detail
Table 48. Pfizer Business Overview
Table 49. Pfizer Knee Bursitis Treatment Product
Table 50. Pfizer Revenue in Knee Bursitis Treatment Business (2017-2022) & (US$ Million)
Table 51. Pfizer Recent Development
Table 52. Merck Company Detail
Table 53. Merck Business Overview
Table 54. Merck Knee Bursitis Treatment Product
Table 55. Merck Revenue in Knee Bursitis Treatment Business (2017-2022) & (US$ Million)
Table 56. Merck Recent Development
Table 57. Amgen Company Detail
Table 58. Amgen Business Overview
Table 59. Amgen Knee Bursitis Treatment Product
Table 60. Amgen Revenue in Knee Bursitis Treatment Business (2017-2022) & (US$ Million)
Table 61. Amgen Recent Development
Table 62. Bayer Company Detail
Table 63. Bayer Business Overview
Table 64. Bayer Knee Bursitis Treatment Product
Table 65. Bayer Revenue in Knee Bursitis Treatment Business (2017-2022) & (US$ Million)
Table 66. Bayer Recent Development
Table 67. AVEO Pharmaceuticals Company Detail
Table 68. AVEO Pharmaceuticals Business Overview
Table 69. AVEO Pharmaceuticals Knee Bursitis Treatment Product
Table 70. AVEO Pharmaceuticals Revenue in Knee Bursitis Treatment Business (2017-2022) & (US$ Million)
Table 71. AVEO Pharmaceuticals Recent Development
Table 72. Bellicum Pharmaceuticals Company Detail
Table 73. Bellicum Pharmaceuticals Business Overview
Table 74. Bellicum Pharmaceuticals Knee Bursitis Treatment Product
Table 75. Bellicum Pharmaceuticals Revenue in Knee Bursitis Treatment Business (2017-2022) & (US$ Million)
Table 76. Bellicum Pharmaceuticals Recent Development
Table 77. MediaPharma Company Detail
Table 78. MediaPharma Business Overview
Table 79. MediaPharma Knee Bursitis Treatment Product
Table 80. MediaPharma Revenue in Knee Bursitis Treatment Business (2017-2022) & (US$ Million)
Table 81. MediaPharma Recent Development
Table 82. Merrimack Pharmaceuticals Company Detail
Table 83. Merrimack Pharmaceuticals Business Overview
Table 84. Merrimack Pharmaceuticals Knee Bursitis Treatment Product
Table 85. Merrimack Pharmaceuticals Revenue in Knee Bursitis Treatment Business (2017-2022) & (US$ Million)
Table 86. Merrimack Pharmaceuticals Recent Development
Table 87. Oncolys BioPharma Company Detail
Table 88. Oncolys BioPharma Business Overview
Table 89. Oncolys BioPharma Knee Bursitis Treatment Product
Table 90. Oncolys BioPharma Revenue in Knee Bursitis Treatment Business (2017-2022) & (US$ Million)
Table 91. Oncolys BioPharma Recent Development
Table 92. United Therapeutics Company Detail
Table 93. United Therapeutics Business Overview
Table 94. United Therapeutics Knee Bursitis TreatmentProduct
Table 95. United Therapeutics Revenue in Knee Bursitis Treatment Business (2017-2022) & (US$ Million)
Table 96. United Therapeutics Recent Development
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Knee Bursitis Treatment Market Share by Type: 2021 VS 2028
Figure 2. Medication Features
Figure 3. Surgery Therapy Features
Figure 4. Others Features
Figure 5. Global Knee Bursitis Treatment Market Share by Application in 2021 & 2028
Figure 6. Hospitals Case Studies
Figure 7. Clinics Case Studies
Figure 8. Dermatology Centers Case Studies
Figure 9. Others Case Studies
Figure 10. Knee Bursitis Treatment Report Years Considered
Figure 11. Global Knee Bursitis Treatment Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 12. Global Knee Bursitis Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Knee Bursitis Treatment Market Share by Region: 2021 VS 2028
Figure 14. Global Knee Bursitis Treatment Market Share by Players in 2021
Figure 15. Global Top Knee Bursitis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Knee Bursitis Treatment as of 2021)
Figure 16. The Top 10 and 5 Players Market Share by Knee Bursitis Treatment Revenue in 2021
Figure 17. North America Knee Bursitis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 18. North America Knee Bursitis Treatment Market Share by Country (2017-2028)
Figure 19. United States Knee Bursitis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Canada Knee Bursitis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Europe Knee Bursitis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Europe Knee Bursitis Treatment Market Share by Country (2017-2028)
Figure 23. Germany Knee Bursitis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. France Knee Bursitis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. U.K. Knee Bursitis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Italy Knee Bursitis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Russia Knee Bursitis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Nordic Countries Knee Bursitis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Asia-Pacific Knee Bursitis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Asia-Pacific Knee Bursitis Treatment Market Share by Region (2017-2028)
Figure 31. China Knee Bursitis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Japan Knee Bursitis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. South Korea Knee Bursitis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Southeast Asia Knee Bursitis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. India Knee Bursitis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Australia Knee Bursitis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Latin America Knee Bursitis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Latin America Knee Bursitis Treatment Market Share by Country (2017-2028)
Figure 39. Mexico Knee Bursitis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Brazil Knee Bursitis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Middle East & Africa Knee Bursitis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Middle East & Africa Knee Bursitis Treatment Market Share by Country (2017-2028)
Figure 43. Turkey Knee Bursitis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Saudi Arabia Knee Bursitis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. Novartis Revenue Growth Rate in Knee Bursitis Treatment Business (2017-2022)
Figure 46. Pfizer Revenue Growth Rate in Knee Bursitis Treatment Business (2017-2022)
Figure 47. Merck Revenue Growth Rate in Knee Bursitis Treatment Business (2017-2022)
Figure 48. Amgen Revenue Growth Rate in Knee Bursitis Treatment Business (2017-2022)
Figure 49. Bayer Revenue Growth Rate in Knee Bursitis Treatment Business (2017-2022)
Figure 50. AVEO Pharmaceuticals Revenue Growth Rate in Knee Bursitis Treatment Business (2017-2022)
Figure 51. Bellicum Pharmaceuticals Revenue Growth Rate in Knee Bursitis Treatment Business (2017-2022)
Figure 52. MediaPharma Revenue Growth Rate in Knee Bursitis Treatment Business (2017-2022)
Figure 53. Merrimack Pharmaceuticals Revenue Growth Rate in Knee Bursitis Treatment Business (2017-2022)
Figure 54. Oncolys BioPharma Revenue Growth Rate in Knee Bursitis Treatment Business (2017-2022)
Figure 55. United Therapeutics Revenue Growth Rate in Knee Bursitis Treatment Business (2017-2022)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed